1 Jun 2022 13:00
1 June 2022
Ideagen PLC
("Ideagen," "the Company" or the "Group'')
Total Voting Rights
In line with the Financial Conduct Authority's Disclosure and Transparency Rules, Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that as at today's date, the Company's total issued share capital is 293,853,523 ordinary shares of 1p each ("Ordinary Shares") and the total number of voting rights will therefore be 293,853,523.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Enquiries:
Ideagen plc | 01629 699 100 |
Ben Dorks, Chief Executive Officer | |
Emma Hayes, Chief Financial Officer
| |
Canaccord Genuity Limited (Nomad) | 020 7523 8000 |
Simon Bridges |
|
Georgina McCooke |
|
|
|
|
|
Numis Securities Limited | 0207 260 1267 |
Simon Willis |
|
Joshua Hughes |
|
|
|
FTI Consulting | 020 3727 1000 |
Jamie Ricketts | ideagen@fticonsulting.com |
Dwight Burden | |
Valerija Cymbal |
About Ideagen plc
Ideagen's software helps companies comply with regulation and manage risk.
Ideagen is a leader in the +$30 billion regulatory and compliance software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance.
More than 10,000 customers use Ideagen's software, including leading accounting and pharmaceutical firms.
Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, Aggreko, Bank of New York and Johnson Matthey.
Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, USA, Middle East and South East Asia. For further information please visit www.ideagen.com.